The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MDS 2023 | The importance of monitoring genetic predispositions to bone marrow failure syndromes
Jean Soulier, MD, PhD, Saint-Louis Hospital, Paris, France, comments on genetic predispositions to bone marrow failure syndromes, drawing focus on Fanconi anemia (FA), and highlighting the importance of monitoring these mutations regularly. This interview took place at the 17th International Congress on Myelodysplastic Syndromes 2023 (MDS 2023) held in Marseille, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Scientific Advisor for STRM.BIO
